IBB Holdings Information

IBB is an equity ETF with a total of 257 individual holdings. The top holdings are Amgen stock at 7.46%, Gilead Sciences at 7.35%, Vertex Pharmaceuticals at 7.20%, Regeneron Pharmaceuticals at 6.67%, and Alnylam Pharmaceuticals at 3.77%.

Total Holdings

257

Top 10 Percentage

45.83%

Asset Class

Equity

ETF Category

Health

Assets

7.93B

PE Ratio

22.05

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	AMGN	Amgen Inc.	7.46%	1,723,744
2	GILD	Gilead Sciences, Inc.	7.35%	4,492,040
3	VRTX	Vertex Pharmaceuticals Incorporated	7.20%	1,346,719
4	REGN	Regeneron Pharmaceuticals, Inc.	6.67%	753,886
5	ALNY	Alnylam Pharmaceuticals, Inc.	3.77%	973,961
6	ARGX	argenx SE	3.32%	339,613
7	INSM	Insmed Incorporated	2.69%	1,578,690
8	BIIB	Biogen Inc.	2.57%	1,084,844
9	NTRA	Natera, Inc.	2.51%	975,027
10	RVMD	Revolution Medicines, Inc.	2.30%	1,276,194
11	UTHR	United Therapeutics Corporation	2.24%	313,663
12	ONC	BeOne Medicines AG	1.94%	526,206
13	ILMN	Illumina, Inc.	1.74%	1,100,982
14	INCY	Incyte Corporation	1.74%	1,459,404
15	MRNA	Moderna, Inc.	1.54%	2,676,270
16	ROIV	Roivant Sciences Ltd.	1.29%	3,618,521
17	NBIX	Neurocrine Biosciences, Inc.	1.19%	723,331
18	GMAB	Genmab A/S	1.17%	3,536,142
19	IONS	Ionis Pharmaceuticals, Inc.	1.12%	1,198,520
20	BBIO	BridgeBio Pharma, Inc.	1.10%	1,231,544
21	EXEL	Exelixis, Inc.	1.03%	1,861,184
22	MDGL	Madrigal Pharmaceuticals, Inc.	1.00%	154,475
23	ASND	Ascendis Pharma A/S	0.97%	338,060
24	BMRN	BioMarin Pharmaceutical Inc.	0.95%	1,404,282
25	ARWR	Arrowhead Pharmaceuticals, Inc.	0.89%	969,344

Showing 25 of 257 holdings

Subscribe to see the full list

Activate Now

As of Apr 30, 2026